Literature DB >> 17058977

[Prevalence of use of alternative and complementary medicine in patients with irritable bowel syndrome, functional dyspepsia and gastroesophageal reflux disease].

Ramón Carmona-Sánchez1, Fernando Alvarez Tostado-Fernández.   

Abstract

INTRODUCTION: The prevalence of use of complementary and alternative medicine (CAM) is high in developed countries and is believed to be even higher in developing countries. There are no data on the use of CAM in patients with gastrointestinal tract disorders in Mexico.
OBJECTIVE: To determine the prevalence of CAM use in Mexican patients with gastrointestinal disorders.
MATERIAL AND METHODS: A survey was applied to all first-time patients presenting at the gastroenterology service between December 2003 and November 2004. Patients with irritable bowel syndrome (IBS, defined by Rome II), functional dyspepsia (FD, defined by Rome II), and gastroesophageal reflux disease (GERD, defined as erosive esophagitis or abnormal pH intraesophageal monitoring) were included. The use of CAM to relieve gastrointestinal symptoms was examined and the demographic data, the disease history and healthcare use 12 months prior to the study were recorded.
RESULTS: The survey was answered by 413 patients (61% IBS, 22% FD y 17% GERD). A total of 181 users of CAM were identified (44% of the total group). The use of CAM was most frequent for IBS (51% IBS, 36% FD, 27% GERD). Herbal medicine was the type of CAM most often used by all groups. The factors associated with CAM use were IBS, history of abdominal surgery, emergency room visits, disabilities and prescription of benzodiazepines, and > or = 3 medical visits for gastrointestinal tract disorders within the previous year.
CONCLUSIONS: Prevalence of CAM use is high in general and significantly higher for IBS. Herbal medicine is the most frequently used modality.

Entities:  

Mesh:

Year:  2005        PMID: 17058977

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  8 in total

1.  A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders.

Authors:  Edith Lahner; Stefano Bellentani; Rudy De Bastiani; Cesare Tosetti; Michele Cicala; Gianluca Esposito; Paolo Arullani; Bruno Annibale
Journal:  United European Gastroenterol J       Date:  2013-10       Impact factor: 4.623

Review 2.  Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?

Authors:  Anna Matheis; Ute Martens; Johannes Kruse; Paul Enck
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

3.  Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.

Authors:  Ji-Meng Zhao; Lu-Yi Wu; Hui-Rong Liu; Hong-Yi Hu; Jia-Ying Wang; Ren-Jia Huang; Yin Shi; Shan-Ping Tao; Qiang Gao; Ci-Li Zhou; Li Qi; Xiao-Peng Ma; Huan-Gan Wu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

4.  Desperately seeking a cure: Treatment seeking and appraisal in irritable bowel syndrome.

Authors:  J Matthew Harvey; Alice Sibelli; Trudie Chalder; Hazel Everitt; Rona Moss-Morris; Felicity L Bishop
Journal:  Br J Health Psychol       Date:  2018-03-05

Review 5.  Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis.

Authors:  Haizhen Zheng; Rixin Chen; Xiaofeng Zhao; Guanhui Li; Yi Liang; Hao Zhang; Zhenhai Chi
Journal:  Pain Res Manag       Date:  2019-11-11       Impact factor: 3.037

Review 6.  Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic Review.

Authors:  Florent Amsallem; Stéphane Sanchez; Xavier Armoiry; François Mion
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-08       Impact factor: 2.629

7.  Treatments for irritable bowel syndrome: patients' attitudes and acceptability.

Authors:  Lynsey R Harris; Lesley Roberts
Journal:  BMC Complement Altern Med       Date:  2008-12-19       Impact factor: 3.659

Review 8.  Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Bozong Tang; Jianliang Zhang; Zongguo Yang; Yunfei Lu; Qingnian Xu; Xiaorong Chen; Jiang Lin
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-16       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.